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Fumonisin B1 (FB1) (Structure 1) is the
primary mycotoxin produced by Fusarium
verticillioides Nirenberg (= Fusarium monili-
forme Sheldon). Its structure and biosynthesis
have been the subject of extensive studies by
our group [(1–5) and references therein] and
others (6–8).
Along with FB1, a large number of related
congeners have been reported, as summarized
in Structure 2.
Biosynthesis of FB1
Fumonisins are structurally similar to the
sphingoid base backbone of sphingolipids,
prompting the idea that they may be biosyn-
thetically related (9,10). The biosynthesis of
sphingosine proceeds via the condensation of
palmitoyl coenzyme A (CoA) with serine.
Past studies have shown the advantage of
incorporating specifically enriched 13carbon
(C)-acetate into fungal cultures at the appro-
priate time of biosynthesis of a particular
metabolite as a preliminary step to preparing
radiolabeled (14C) compounds for toxicologic
research (11,12). The 13C studies permit
determination of the most cost-effective
method to manufacture highly enriched 14C-
FB1 labeled in multiple locations for use in
radiotracer studies. An earlier study has
shown that the 13C-acetate is incorporated
into the fumonisin backbone in a manner
more suggestive of polyketide biosynthesis
than of lipid biosynthesis, but the analyses
were performed on impure FB1 (13).
In our laboratories, we incorporated
specifically enriched 13C-acetate (13C-1 and
13C-2) as well as 13C-3 L-alanine, 13C-5
L-glutamic acid, 13C-3 L-serine, and 13C-CH3
L-methionine into 50 mL cultures of
F. moniliforme as previously described (11,12).
The precursors were added as small aliquots
spread over a 24 hr in a manner designed to
coordinate with the onset of rapid fumonisin
production. FB1 was puriﬁed from the fungal
extracts in a manner similar to that used for
the 10 L cultures, only on a smaller scale.
The pattern of acetate incorporation illus-
trated in Structure 3 is consistent with the
head-to-tail pattern from the condensation of
acetyl CoA units expected from both lipid
and polyketide biosynthesis. However, the
pattern alone cannot distinguish between the
two pathways. The fact that substantial
enrichment has occurred after initial lipid
synthesis has occurred in cultures that are not
carbon-compromised favors the polyketide
pathway. In addition, the hydroxyl functions
at C-3, C-5, and C-15 are in the correct posi-
tion for oxidation from polyketide carbonyl
groups, and the polyketide model is more
ﬂexible in patterns of substitution. The large
number of functionalities would be difficult
to evoke from stearic or oleic CoA.
The label from C-3 of alanine was incor-
porated into C-1 of fumonisin in agreement
with previous studies (14). However, alanine
was also catabolized as evidenced by the label-
ing of the even positions of the backbone and
the ester functions, although to a lesser
extent. 13C-3 serine showed poor incorpora-
tion, producing some increase in the intensi-
ties of the resonances caused by C-1 and the
backbone carbons but also by the C-21 and
C-22 methyl groups. Why these methyl
groups were enriched by serine but not ala-
nine is unclear, but may indicate the greater
extent of catabolism of serine and the more
direct incorporation of alanine into fumon-
isin. Under no conditions was C-2 enriched,
indicating that “scrambling of labeled atoms”
was minimal. The S-CH3 group of methion-
ine was incorporated uniquely and efﬁciently
into the C-21 and C-22 methyl functions, as
predicted by previous studies using deuterium
enrichment and mass spectrometric analysis
(10). Plattner and Branham (15) have used
this efﬁcient incorporation of methionine to
produce stable, highly enriched deuterated
FB1 (FB1–d6) to be used as an analytic stan-
dard for accurate quantitation of fumonisins
by gas chromatography/mass spectography or
fast atom bombardment/mass spectography
techniques. Glutamic acid was incorporated
least efficiently into FB1, but showed a
unique enrichment of the secondary carboxyl
functions of both side chains at C-28 and
C-34. When combined with the data from
acetate enrichment, this indicates that the
precursor to esteriﬁcation involves a conden-
sation between α-keto glutarate (the deami-
nated precursor of glutamate) and a second
acetyl CoA unit. Enrichment in the side
chains is less than in the backbone of the
fumonisin (approximately a factor of 2) and is
unevenly distributed—the two carbons at the
esteriﬁed end receiving somewhat less of the
label than the other carbons—for both of the
tricarballylic groups. This suggests that a
4-carbon unit is formed ﬁrst, likely from the
Krebs acid cycle, and a third acetate unit is
added later. The precursor to the esterifica-
tion step must therefore be unsymmetrical,
because symmetry would induce an even
labeling pattern.
The condensation of alanine with an
18-C polyketide chain confirms previous
studies on Alternaria alternata f. sp. lycoper-
sici (AAL) toxin, where alanine was shown
to be directly incorporated into the C-1 and
C-2 positions (16). The array of functional-
ities is consistent with the carbonyl deriva-
tion of the hydroxyl groups at C-3, C-5,
and C-15, subsequent hydroxylation at C-
10 and C-14, methionine-derived methyla-
tion at C-12 and C-16, followed by
esterification by a precursor yet to be
defined. Less incorporation of acetate into
the side chains suggests that this precursor is
formed earlier or later than the fumonisin
backbone, and that esterification occurs
after the C-14 and C-15 hydroxyl groups
are formed. 
Caldas and co-workers (17) have demon-
strated that the oxygen atoms in fumonisin
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are derived from molecular oxygen for the
backbone and from water for the tricar-
ballylic acids that esterify positions 15 and
16 (Structure 1). These observations are
entirely consistent with the biosynthesis
proposals described. 
Stereochemistry of FB1
Examination of the structure of FB1 shows
that the molecule contains 10 stereocenters,
providing a possible 1,024 different stereo-
chemical structures (1). The presence of a sin-
gle unique high-resolution nuclear magnetic
resonance (1H NMR) spectrum for FB1
derived from different species of Fusarium and
isolated by different methods suggests that
only one of these 1,024 structures describes
FB1. Because fumonisin does not crystallize,
several groups have been involved in determin-
ing the stereochemistry through the synthesis
of derivatives and NMR analysis thereof (1–8).
To date, all have come to the same conclusions
using different derivatization schemes.
Hoping to obtain a crystalline compound
for X-ray analysis, we prepared several deriva-
tives containing “bulky” functions and semi-
rigid units in our laboratories. All of the
derivatives failed to crystallize, but their spec-
tral properties revealed the relative stereo-
chemistry for portions of the FB1 backbone.
The synthetic strategy is summarized in
Figure 1. Generally the derivatives were
formed from tetramethyl FB1 [FB1(CH3)4]
where the carboxylic groups have been
methylated so that organic solvents could be
used in the puriﬁcation steps and so as not to
involve the tricarballylic ester functions.
FB1(CH3)4 (Structure 1 with COOMe for
COOH) was converted to the 2,3-carbamate
(2) using phosgene and triethylamine in ben-
zene. The 3,5-carbonate (5) was prepared
using phosgene in pyridine after protecting
the amide function with N-p-bromobenzoate.
We used these two compounds to determine
the relative stereochemistry of the C-1 to C-5
fragment of FB1 as shown in Structure 1,
using coupling constants and nuclear
Overhauser effects (nOe). A parallel study (7)
conﬁrmed these results. 
Compound 7 was obtained by taking
advantage of the adventitious formation of
chloro-compound 6 (see Figure 1), which on
treatment with potassium hydroxide in
ethanol provided the pyran 7. 
Analysis of nOe data defines the relative
configuration of the 6-membered ring
of Structure 7 as shown in Figure 2.
Enchancements were observed between H-
10, H-12, and H-15, but not between H-10
and H-14, thus indicating these protons to
be trans. We determined the relative stereo-
chemistry of the C-10 to C-16 moiety by
comparing the NMR parameters of FB1 to
those of the 10,14-cyclic ether derivative of
Structure 1. FB1. 
Structure 2. Variety of FB1-related congeners. 
Structure 3. Incorporation of acetate in FB1. 
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N-p-bromobenzoate FB1 aminopentanol
(Structure 7). 
With the relative configuration of two
portions of the molecule thus defined, the
absolute stereochemistry at any one position
must be determined to define the absolute
stereochemistry at each asymmetric center.
Mosher’s method (18) was applied directly to
FB1 to form the α-methoxy-α-trifluo-
romethylphenylacetyl (MPTA) amide deriva-
tives in a method similar to that of Hoye et
al. (8), except that in this case positions C-3
and C-5 were underivatized. FB1(CH3)4 was
treated with MPTA chloride in tetrahydrofu-
ran (THF) for 30 min and the amides puri-
fied on silica using 10% methanol in
chloroform. The S-amide was prepared using
the R-MPTA chloride, and the R-amide was
prepared using the S-MPTA chloride. NMR
analysis and comparison of the magnitude
and sign of the differences in the proton
chemical shifts between the two amides (18)
determined that the absolute conﬁguration at
C-2 was S (as shown in Structure 1), identical
to that of the naturally occuring amino acids.
L-alanine is incorporated with retention of
conﬁguration into FB1. 
The resultant absolute configuration of
the FB1 backbone is therefore as shown in
Structure 1. The connection between C-10
and C-5 was provided by the hexanoic acid
derivative of Hoye et al. (8). This also agrees
with the studies of Harmange et al. on FB2
(19) and shows that the fumonisins have the
same absolute conﬁguration as the AAL tox-
ins as determined by Boyle et al. (20). The
configuration of the side chains was sug-
gested to be S (21) and more recently argued
to be R in studies on FB2 by Kishi and
colleagues (22,23). 
Hartl and Humpf have confirmed the
absolute conﬁguration of the amino terminus
(C-1 → C-5) using the circular dichroism
exciton method (24). 
The disagreement that has surfaced over
the stereochemistry of the two tricarballylic
acid (TCA) esters present at positions C-14
and C-15 in this and related molecules led us
to examine an independent route to determine
the stereochemistry of the side chain acids. 
We began by stabilizing the asymmetric
centers in the TCA units of FB1 by borane
reduction of the free carboxyl groups, as was
also done by Shier et al. (21). In practice, this
required solubilization of FB1 in THF, which
was accomplished by conversion to the
N-acetyl-O-triacetate bis-anhydride Structure
8a, using acetic anhydride. This was followed
by partial hydrolysis in aqueous THF at room
temperature to the acid Structure 8B, a com-
pound that is the triacetate of the naturally
occurring fumonisin A1, (FA1) ﬁrst described
by Bezuidenhout et al. (6). Reduction of
Structure 8b using excess THF/BH3, in THF
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Figure 1. Synthesis of cyclic derivations of FB1 tetramethyl ester.
Figure 2. NMR analysis of cyclic derivatives of FB1. 
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gave the N-acetyl triacetyl tetraol Structure 8c,
which is identical to compound 1C described
by Shier et al. (21). Complete hydrolysis of
Structure 8c using potassium hydroxide in
aqueous methanol, followed by acidification
gave a mixture rich in hydroxy γ-lactone
(Structure 9) (R = H). Benzoylation of this
mixture and separation on SiO2 using 1:1 ethyl
acetate/hexane produced the benzoyloxy
γ-lactone Structure 9 (R = COC6H5).
An authentic sample of optically active
Structure 9 (R = COC6H5) was prepared
from E-phenylitoconic acid (Structure 10) by
asymmetric reduction (25) to S(–) benzyl-
succinic acid Structure 11 [(α)D
25-27° (c 1.5,
ethyl acetate)]. The absolute stereochemistry
assigned to this (25,26) was confirmed by
X-ray crystallography. Conversion of
Structure 11 to the diol Structure 12 using
borane-THF, then benzoylation and oxida-
tion gave the dibenzoyloxy acid Structure 13.
Alkaline hydrolysis followed by acidification
gave the R(–) hydroxy γ-lactone Structure 9
(R = H) identified in all respects to the
product obtained from FB1.
It follows that both the TCA units in FB1
have the R configuration illustrated in
Structure 14. Thus, our conclusions agree
with those of Boyle and Kishi (22). Our
detailed NMR assignments for the carbons
and hydrogens of the TCA units in FB1 (as
well as FB2 and FB3) (2,18) agree well with
those in the literature (13), making it improb-
able that two optical isomers of FB1 have been
isolated. It is evident both from our work and
that of Boyle and Kishi (22) that only one
conﬁguration exists for the TCA units at both
the C-14 and C-15 positions in the backbone
for all the fumonisins isolated to date.
Moreover, it is interesting to observe that no
fumonisin has yet been isolated with TCA
units at any other position on the backbone,
implying a biosynthetic preference for those
sites. Comparison of the present results with
previous biosynthetic studies (5,12) raise an
intriguing question with respect to the biosyn-
thetic origin of these TCA units. Studies using
13C-enriched glutamate have shown that the
secondary carboxyl functions (C-28 and C-
34) are derived from C-5 of L-glutamic acid,
whereas studies with 13C-enriched acetate
have shown that the unesteriﬁed four-carbon
unit of the TCA unit (C-25, C-26, C-27, C-
28, and C-31, C-32, C-33, C-34) is formed
before the addition of a third acetate unit
(leading to C-23, C-24 and C-29, C-30). The
specific incorporation of glutamic acid
suggests that the TCA units are derived from
the Krebs acid cycle. 
These results can be explained by three
possible mechanisms: a) simple chiral esteriﬁ-
cation using TCA itself; b) esteriﬁcation with
cis-aconitate as in Structure 15, followed by
chiral reduction of the double bonds; or c)
esterification with the chiral intermediate
2R-3S isocitrate to give Structure 16, fol-
lowed by deoxygenation at C-24 and C-30.
In the latter case, the R conﬁguration of the
TCA units would arise, consistent with the
Structure 8. Derivatives of FB1 required to determine
side chain stereochemistry.
Structures 9–13. Synthetic compounds prepared to study side chain stereochemistry. 
Structures 14–16. Possible biosynthetic origins of the side chains of FB1.
Figure 3. Basic strategy behind the two fumonisin syntheses; subunits shown below the target structures. 
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results presented here. Obviously more work
is needed to address this question.
We therefore confirm that the absolute
stereochemical description of FB1 is that
shown in Structure 1. 
Synthetic Approaches to FB1
One report discusses the stereoselective syn-
thesis of the fumonisin skeleton (27), and
another presents a related synthesis of AAL-
toxin TA1 that possess many of features pre-
sent in the fumonisin (28). These elegant
stereoselective syntheses open the route of the
synthesis of previously undescribed analogs of
the fumonisin susceptible to a study of their
structure/activity relationships. This basic
strategy behind the two fumonisin syntheses is
outlined in Figures 3 and 4, where the sub-
units that were assembled during the synthetic
routes are shown below the target structures,
with indications of the eventual carbon sites.
Summary
The studies described in this brief review
demonstrate the absolute stereochemistry of
the fumonisins, provide extensive information
on their biosynthesis, and reveal that the total
synthesis of these molecules is achievable. The
determination of the absolute stereochemistry
of FB1 has been achieved, providing a sound
basis for a deeper understanding of the struc-
tural basis for the biologic effects of this class
of mycotoxins.
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Figure 4. Basic strategy behind the two fumonisin syn-
theses; subunits shown below the target structures. 
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